LOG IN
SIGN UP
MARKET
MLSS
MLSS
Milestone Scient
AMEX
Real-time Quotes | Nasdaq Last Sale
0.9601
+0.0222
+2.37%
Closed 16:00 05/26 EDT
OPEN
0.9565
PREV CLOSE
0.9379
HIGH
1.020
LOW
0.9504
VOLUME
80.66K
TURNOVER
38.25K
52 WEEK HIGH
3.000
52 WEEK LOW
0.7500
MARKET CAP
65.70M
P/E (TTM)
-8.5877
1D
5D
1M
3M
1Y
5Y
BRIEF-Milestone Scientific Appoints Benedetta Casamento To Its Board Of Directors
reuters.com · 3d ago
Milestone Scientific: Q1 Earnings Insights
Milestone Scientific (AMEX:MLSS) reported its Q1 earnings results on Tuesday, May 17, 2022 at 07:00 AM. Here's what investors need to know about the announcement. Earnings Milestone Scientific reported in-line EPS of $-0.03 versus an estimate of $-0.03.
Benzinga · 05/17 11:46
Milestone Scientific Q1 EPS $(0.03), Inline, Sales $2.70M Beat $2.50M Estimate
Milestone Scientific (AMEX:MLSS) reported quarterly losses of $(0.03) per share which met the analyst consensus estimate. This is a 200 percent decrease over losses of $(0.01) per share from the same period last year.
Benzinga · 05/17 11:10
Milestone Scientific GAAP EPS of -$0.03 in-line, revenue of $2.7M misses by $0.19M
Milestone Scientific press release (NYSE:MLSS): Q1 GAAP EPS of -$0.03 in-line. Revenue of $2.7M (-6.9% Y/Y) misses by $0.19M. “Overall, we believe we are well positioned for the balance of
Seekingalpha · 05/17 11:06
A Preview Of Milestone Scientific's Earnings
Milestone Scientific (AMEX:MLSS) is set to give its latest quarterly earnings report on Tuesday, 2022-05-17. Here's what investors need to know before the announcement. Analysts estimate that Milestone Scientific will report an earnings per share (EPS) of ...
Benzinga · 05/16 15:03
Milestone Scientific Schedules First Quarter 2022 Financial Results and Business Update Conference Call
ROSELAND, N.J., May 13, 2022 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments, that provide painless and precise injections, today announced that it will host a conference call at 8:30...
GlobeNewswire · 05/13 15:00
66 Biggest Movers From Yesterday
Gainers Better Therapeutics, Inc. (NASDAQ: BTTX) shares surged 120.4% to close at $2.01 on Monday following a 5% drop on Friday.
Benzinga · 05/03 10:08
Milestone Scientific to Present at Investor Summit Group's Q2 In-Person Conference on May 3rd in NYC
Roseland, New Jersey--(Newsfile Corp. - April 29, 2022) - Milestone Scientific Inc. (NYSE American: MLSS), a leading developer of computerized drug delivery instruments, that provide painless and precise injections, today announced that Arjan Haverhals, Pr...
Newsfile · 04/29 17:16
No Data
Learn about the latest financial forecast of MLSS. Analyze the recent business situations of Milestone Scient through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating
Based on 1 analysts
Buy
Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.
0.00%Strong Buy
100.00%Buy
0.00%Hold
0.00%Under-perform
0.00%Sell
Analyst Price Target
The average MLSS stock price target is 4.000 with a high estimate of 4.000 and a low estimate of 4.000.
Current 0.9601
EPS
Actual
Estimate
-0.03-0.02-0.02-0.01
Institutional Holdings
Institutions: 20
Institutional Holdings: 2.47M
% Owned: 3.61%
Shares Outstanding: 68.43M
TypeInstitutionsShares
Increased
4
88.90K
New
1
13.23K
Decreased
2
3.96K
Sold Out
2
121.90K
- Performance
- Asset Allocation
- Dividend History
No Data
Industry
Advanced Medical Equipment & Technology
+0.61%
Healthcare Equipment & Supplies
+0.56%
Key Executives
Non-Executive Chairman/Independent Director
Leslie Bernhard
President/Chief Executive Officer
Jan Haverhals
Vice Chairman/Director
Leonard Osser
Chief Financial Officer
Scott Kahn
Vice President
Chet Trechock
Other
Eugene Casagrande
Other
Mark Hochman
Director
Benedetta Casamento
Director
Gian Trombetta
Independent Director
Neal Goldman
Independent Director
Michael McGeehan
Independent Director
Leonard Schiller
No Data
No Data
About MLSS
Milestone Scientific Inc. (Milestone) is a biomedical technology company. The Company is engaged in research and development that patents, designs, develops and commercializes diagnostic and therapeutic injection technologies and devices for medical, dental and cosmetic. The Company operates through two segments: Dental and Medical. Dental segment provides a Single Tooth Anesthesia System (STA). The STA instrument is a computer assisted system for local anesthesia. Medical segment includes products, such as CompuFlo and CathCheck. The CompuFlo instrument offers objective detection of pressure changes to verify true loss of resistance and confirm epidural space within minutes. The CathCheck verification system shows pulsatile waveform found in the epidural space.
Webull offers kinds of Milestone Scientific Inc. stock information, including AMEX:MLSS real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, MLSS stock news, and many more online research tools to help you make informed decisions.
You can practice and explore trading MLSS stock methods without spending real money on the virtual paper trading platform.